Singular Genomics Systems Inc reports results for the quarter ended in December - Earnings Summary

Singular Genomics Systems

03/03/2022 05:31

* Singular Genomics Systems Inc  OMIC.OQ  reported a
quarterly
adjusted loss of 27 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 31 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Singular Genomics Systems Inc's reported EPS for the
quarter was
a loss of 27 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.4%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Singular Genomics Systems Inc shares had fallen by 32.7%
this
quarter.
    * The company reported a quarterly loss of $19.76 million.
    * Wall Street's median 12-month price target for Singular
Genomics
Systems Inc is $21.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 3 at 05:31 a.m.  ​All
figures in US dollars unless otherwise stated